Identification of A Novel Mutation in RYR1 Gene in Malignant Hyperthermia-Like Patient's Family Members

Allen, G. C., Rosenberg, H., Fletcher, J. E. (1990). Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility. Anesthesiology, 72(4), 619-622.10.1097/00000542-199004000-00007Search in Google Scholar

Bonciu, M., Chapelle, A., Delpech, H., Depret, T., Krivosic-Horber, R., Aime, M. R. (2007). Minor increase of endtidal CO2 during sevoflurane induced malignant hyperthermia. Pediatric Anesthesia, 17, 180-182.10.1111/j.1460-9592.2006.02051.xSearch in Google Scholar

Cohen, I. T., Kaplan, R. (2006). Repeat episodes of severe muscle rigidity in a child receiving sevoflurane. Paediatric Anaesthesia. 16(10), 1077-1079.10.1111/j.1460-9592.2006.01920.xSearch in Google Scholar

Denbrough, M. (1998). Malignant hyperthermia. Lancet, 352, 1131-1136.10.1016/S0140-6736(98)03078-5Search in Google Scholar

Denborough, M. A., Lowell, R. H. (1960) Anaesthetic deaths in a family (letter). Lancet, 2, 45.10.1016/S0140-6736(60)92690-8Search in Google Scholar

Greenberg, D. A. (1999). Muscle & Nerve, 22(10), 1341-1349.10.1002/(SICI)1097-4598(199910)22:10<1341::AID-MUS2>3.0.CO;2-9Search in Google Scholar

Halsall, P. J., Cain, P. A., Ellis, F. R. (1979). Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognised. Brit. J. Anaesth., 51, 949-954.10.1093/bja/51.10.949Search in Google Scholar

Islander, G., Ranklev-Twetman, E. (1995). Evaluation of anaesthesias in malignant hyperthermia negative patients. Acta Anaesthesiol. Scand, 39(6), 819-821.10.1111/j.1399-6576.1995.tb04177.xSearch in Google Scholar

Krause, T., Gerbershagen, M. U., Fiege, M., Weisshorn, R., Wappler, F. (2004). Dantrolene—a review of its pharmacology, therapeutic use and new developments. Anaesthesia, 59(4), 364-373.10.1111/j.1365-2044.2004.03658.xSearch in Google Scholar

Larach, M. G., Brandom, B. W., Allen, G. C., Gronert, G. A., Lehman, E. B. (2008). Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: A report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesthesiology, 108(4), 603-611.10.1097/ALN.0b013e318167aee2Search in Google Scholar

Ording, H., Hedengran, A. M., Skovgaard, L. T. (1991). Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia. Acta Anaesthesiol. Scand., 35(8), 711-716.10.1111/j.1399-6576.1991.tb03377.xSearch in Google Scholar

Ording, H., Brancadoro, V., Cozzolino, S., Ellis, F. R., Glauber, V., Gonano, E. F., Halsall, P. J., Hartung, E., Heffron, J. J., Heytens, L., Kozak-Ribbens, G., Kress, H., Krivosic-Horber, R., Lehmann-Horn, F., Mortier, W., Nivoche, Y., Ranklev-Twetman, E., Sigurdsson, S., Snoeck, M., Stieglitz, P., Tegazzin, V., Urwyler, A., Wappler, F. (1997). In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol. Scand., 41(8), 955-966.10.1111/j.1399-6576.1997.tb04820.xSearch in Google Scholar

Rosenberg, H., Davis, M., James, D., Pollock, N., Stwell, K. (2007). Malignant hyperthermia. Orphanet J. Rare Dis., 24, 2-21.10.1186/1750-1172-2-21Search in Google Scholar

Scala, D., Di Martino, A., Cozzolino, S., Mancini, A., Bracco, A., Andria, B., Tammaro, A., Savoia, G. (2006). Follow-up of patients tested for malignant hyperthermia susceptibility. Eur. J. Anaesthesiol., 23(9), 801-805.10.1017/S0265021506000858Search in Google Scholar

Tammaro, A., Bracco, A., Cozzolino, S., Esposito, M., Di Martino, A., Savoia, G., Zeuli, L., Piluso, G., Aurino, S., Nigro, V. (2003). Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: Detection of three novel malignant hyperthermia alleles. Clin. Chem., 49(5), 761-768.10.1373/49.5.761Search in Google Scholar

Urwyler, A., Deufel, T., McCarthy, T., West, S. (2001) Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. European Malignant Hyperthermia Group. Brit. J. Anaesth., 86(2), 283-287.10.1093/bja/86.2.283Search in Google Scholar

Wappler, F. (2001). Malignant hyperthermia. Eur. J. Anaesthesiol., 18, 632-652.10.1097/00003643-200110000-00002Search in Google Scholar

Wedel, D. J. (1992). Malignant hyperthermia and neuromuscular disease. Neuromuscular Disorders, 2(3), 157-164.10.1016/0960-8966(92)90001-MSearch in Google Scholar

Wehner, M., Rueffert, H., Koenig, F., Neuhaus, J., Olthoff, D. (2002). Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation. Clin. Genet., 62(2), 135-146.10.1034/j.1399-0004.2002.620206.xSearch in Google Scholar